DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
172 hedge funds and large institutions have $1.09B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 53 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
31% less capital invested
Capital invested by funds: $1.59B → $1.09B (-$494M)
71% less call options, than puts
Call options by funds: $3.42M | Put options by funds: $11.8M
Holders
172
Holding in Top 10
4
Calls
$3.42M
Puts
$11.8M
Top Buyers
| 1 | +$13M | |
| 2 | +$9.97M | |
| 3 | +$9.45M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.9M |
Top Sellers
| 1 | -$69.1M | |
| 2 | -$25.7M | |
| 3 | -$17.5M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.41M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.08M |